↓ Skip to main content

PLOS

Clinical Efficacy of Including Capecitabine in Neoadjuvant Chemotherapy for Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Overview of attention for article published in PLOS ONE, January 2013
Altmetric Badge

Mentioned by

twitter
4 X users
f1000
1 research highlight platform

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
27 Mendeley
Title
Clinical Efficacy of Including Capecitabine in Neoadjuvant Chemotherapy for Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Published in
PLOS ONE, January 2013
DOI 10.1371/journal.pone.0053403
Pubmed ID
Authors

Qiuyun Li, Yi Jiang, Wei Wei, Huawei Yang, Jianlun Liu

Abstract

Capecitabine has proven effective as a chemotherapy for metastatic breast cancer. Though several Phase II/III studies of capecitabine as neoadjuvant chemotherapy have been conducted, the results still remain inconsistent. Therefore, we performed a meta-analysis to obtain more precise understanding of the role of capecitabine in neoadjuvant chemotherapy for breast cancer patients.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 27 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 22%
Researcher 5 19%
Student > Ph. D. Student 5 19%
Lecturer 2 7%
Student > Doctoral Student 1 4%
Other 4 15%
Unknown 4 15%
Readers by discipline Count As %
Medicine and Dentistry 12 44%
Nursing and Health Professions 3 11%
Biochemistry, Genetics and Molecular Biology 2 7%
Psychology 2 7%
Environmental Science 1 4%
Other 1 4%
Unknown 6 22%